Pfizer and BioNTech say a third pediatric dose of their COVID-19 vaccine promotes a strong, safe immune response in children 6 months to under 5 years of age.
This article was originally published on WBUR.org.
Copyright 2022 NPR. To see more, visit https://www.npr.org.